Archive for 2019

Clinical Results of Using Amniotic Membrane-Umbilical Cord Graft for Reducing Glaucoma Shunt Tube Exposure Published in Ophthalmology Glaucoma Journal

Bio-Tissue

Study results show that cryopreserved amniotic membrane-umbilical cord (AM-UC) grafts are well tolerated and offer an alternative to pericardium patch grafts for safe and stable glaucoma shunt tube coverage. Miami, FL – December 10, 2019 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of amniotic membrane and umbilical cord birth tissue […]

TissueTech Receives 2019 Customer Digital Transformation Award

Miami, Fla. – December 4, 2019 – TissueTech, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products marketed through its subsidiaries Bio-Tissue, Inc. and Amniox Medical, Inc., was awarded the 2019 Customer Digital Transformation Award by Medidata on November 13, 2019 at Medidata NEXT NYC, the premier conference dedicated to the digital transformation of life sciences. This award recognizes TissueTech’s successful migration to Medidata’s unified data platform and the resultant effectiveness the company has achieved in addressing the complexity of clinical trials and associated data handling.

TissueTech Strengthens Senior Management Team with the Appointment of Vice President of Reimbursement and Government Affairs

Miami, Fla. – December 4, 2019 – TissueTech, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products marketed through its subsidiaries Bio-Tissue, Inc. and Amniox Medical, Inc., announced today the appointment of Timothy Hunter to the position of Vice President, Reimbursement and Government Affairs to oversee enterprise-wide third-party payor and reimbursement activities.    

TissueTech Announces Appointment of New Chief Commercial Officer

Miami, Fla. – November 18, 2019 – TissueTech, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products marketed through its subsidiaries Bio-Tissue, Inc. and Amniox Medical, Inc., announced this week the appointment of Tom Williamson to the position of Chief Commercial Officer (CCO) to support the continued strategic expansion of its marketing, sales and commercial operations.  

Bio-Tissue Launches Website to Educate on Long-Lasting Solution for Mechanical Dry Eye (MDE), aka Conjunctivochalasis (CCh)

Miami, FL – November 12, 2019 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of amniotic membrane and umbilical cord-based products for unmet patient needs, announced today the launch of an educational website, www.DiscoverMDE.com , on Mechanical Dry Eye, MDE, also sometimes referred to as Conjunctivochalasis (CCh). The website features educational information, videos, testimonials and other resources for both patients and health care providers.

Bio-Tissue Founder, Pioneer in Ocular Use of Amniotic Membrane Mentors Minority Students During 2019 American Academy of Ophthalmology Meeting

Scheffer C.G. Tseng, MD, PhD meets with underrepresented undergraduate and medical students to promote diversity in ophthalmology    Miami, FL – November 4, 2019 – Scheffer C.G. Tseng, MD, PhD, Chief Technology Officer and co-founder of Bio-Tissue, Inc., a TissueTech company, shared insights with underrepresented undergraduates and medical students about the rewards and opportunities of […]

Amniox Medical Announces Publication of Phase 2 Clinical Trial Results Utilizing NEOX® CORD 1K (Trial Code Name: TTAX01) in Wound Repair and Regeneration

Data demonstrates 60 percent of wounds achieved complete wound closure, which is compatible with the healing rates observed in previous NEOX Cord 1K retrospective studies. Miami, FL – October 10, 2019 – Miami, FL – October 10, 2019 – Amniox® Medical, Inc. (Amniox), a TissueTechTM, Inc. company and leader in the clinical application of amniotic […]

TissueTech Names New Vice President to Lead Human Resources Operations and Process Improvement Initiatives

Human Birth Tissue Manufacturer is Scaling Up to Transition into a Biologics Provider Miami, FL – October 2, 2019 – TissueTech,TM Inc., a pioneer and market leader in the development and clinical application of human birth tissue products, today announced the appointment of Kim Tripodo to the role of Vice President of Human Resources. In […]

TissueTech Names New Vice President to Oversee Scale Up of Product Lifecycle Management and Technology Transfer Activities

Human Birth Tissue Manufacturer Prepares for Submission of Investigational New Drug Applications and Transition into a Biologics Provider Miami, FL – September 23, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Jerry Chang, PhD to the position of Vice President […]

Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percent

Organization Prepares for Submission of Investigational New Drug Applications and Transition into a Biologics Provider Miami, FL – September 11, 2019 – Bio-Tissue®, Inc., a TissueTech,TM Inc. company, and pioneer and market leader in the development and clinical application of Cryopreserved Amniotic Membrane (CAM) products for ocular surface disease and injury, today announced the expansion […]

Archives

  • 2020
  • 2019
  • 2018
  • 2017